Published in Antibiotiki on November 01, 1984
[A trial of using sulperazone (cefoperazone/sulbactam) in the combined treatment of patients with a burn infection]. Antibiot Khimioter (1995) 0.78
[Penetration of ampicillin and oxacillin into the tissues of rats with aseptic inflammation]. Antibiotiki (1984) 0.77
[Use of cefpirome in the treatment of patients with skin and soft tissue infections]. Antibiot Khimioter (1996) 0.77
[Infection in burn patients: the problems of pathogenesis, prevention and treatment]. Khirurgiia (Mosk) (1999) 0.77
[Multicenter open randomized trial of meropenem in comparison to ceftazidime and amikacin used in combination in severe hospital infections]. Antibiot Khimioter (1998) 0.76
[Comparative experimental study of cyclacillin and ampicillin]. Antibiotiki (1979) 0.75
[Sulfadimethoxine pharmacokinetics in mechanical jaundice and cholangitis]. Antibiotiki (1983) 0.75
[Pharmacokinetics of fluoroquinolones]. Antibiot Khimioter (1993) 0.75
[Symposium: "Ciprofloxacin in clinical practice. New data on the use of the drug"]. Antibiot Khimioter (1991) 0.75
[Effectiveness of cefmetazole in treatment of wound infection]. Antibiot Khimioter (1995) 0.75
[Cefixime-- a new cephalosporin antibiotic for oral administration]. Antibiot Khimioter (1994) 0.75
[Cefoperazone. Antibacterial activity, pharmacokinetic properties, clinical use]. Antibiot Khimioter (1994) 0.75
[Pharmacokinetics of sulfalene and sulfamethoxine after combined administration with benzylpenicillin and ampicillin]. Antibiotiki (1984) 0.75
[Use of imipenem in the treatment of patients with surgical infection]. Antibiot Khimioter (1995) 0.75
[Kinetics of polysynthetic broad spectrum penicillins in rabbits]. Antibiotiki (1970) 0.75
[Antibiotics in complex treatment of chronic suppurative lung diseases]. Grudn Khir (1972) 0.75
[Kinetics of water soluble tetracycline derivatives in the rabbit's body]. Antibiotiki (1971) 0.75
[Use of a combination of cefoperazone with sulbactam for treatment of patients with wound infections]. Antibiot Khimioter (1994) 0.75
[Use of new antibiotics in the treatment of infectious diseases of the urinary organs caused by gram negative bacteria]. Urol Nefrol (Mosk) (1974) 0.75
[Clinical efficacy of ceftizoxime in the treatment and prevention of infectious inflammatory diseases]. Antibiot Khimioter (1993) 0.75
[Experimental-clinical study of a new antibiotic of the tetracycline group called doxycycline]. Eksp Khir Anesteziol (1972) 0.75
[Distribution of chlortetracycline, its dibenzylethylenediamine salt (dibiomycin) and demethylchlortetracycline in experimental animals]. Antibiotiki (1972) 0.75
[Cefmetazole]. Antibiot Khimioter (1994) 0.75
[Absorption and excretion of ampicillin and carbenicillin in surgical cases]. Antibiotiki (1973) 0.75
[Circulation of isoxazolyl penicillins in surgical patients]. Antibiotiki (1971) 0.75
[Ceftizoxime--antibacterial activity, pharmacokinetic properties, clinical application]. Antibiot Khimioter (1994) 0.75
[Use of aztreonam for the purpose of preventing postoperative purulent complications]. Antibiot Khimioter (1996) 0.75
[Distribution of water soluble tetracycline derivatives in the blood and organs of animals]. Antibiotiki (1971) 0.75
[Parenteral administration of macrolytic antibiotics for the treatment and prevention of surgical wound infection]. Sov Med (1973) 0.75
[Use of penicillin and cephalosporin antibiotics in the treatment of pyogenic infection]. Sov Med (1972) 0.75
[Cefodizime--a new 3rd generation cephalosporin antibiotic for parenteral use]. Antibiot Khimioter (1994) 0.75
[The 7th Mediterranean Congress on Chemotherapy]. Antibiot Khimioter (1992) 0.75
[Bacteriological and pathomorphological control of the effectiveness of the therapy of experimental pyocyanic burn infection]. Antibiotiki (1980) 0.75
[Penetration of antibiotics into body cells and intracellular distribution]. Antibiotiki (1971) 0.75
[A new method of antibiotic prophylaxis in liver surgery]. Antibiot Khimioter (1993) 0.75
[Absorption and excretion of oxacillin in patients with urinary calculi]. Antibiotiki (1972) 0.75
[Distribution of morphocycline in blood and organs of rats at different routes of administration]. Antibiotiki (1969) 0.75
[Characteristics of intrarenal ampicillin distribution in chronic pyelonephritis in children]. Antibiot Med Biotekhnol (1987) 0.75
[Study of the binding of polysynthetic penicillins with blood serum proteins]. Antibiotiki (1967) 0.75
[Pharmacokinetics of sulfalene and sulfadimethoxine in chronic pyelonephritis patients]. Antibiot Med Biotekhnol (1987) 0.75
[Experience in the use of ofloxacin in the prevention and treatment of wound infection in burns]. Klin Med (Mosk) (1995) 0.75
[Binding of penicillins by the blood serum in rabbits with experimental anaphylactic inflammation]. Antibiotiki (1971) 0.75
[Pharmacokinetics of cephalexin and cephradine in surgical patients]. Antibiotiki (1977) 0.75
[Pharmacokinetic interference between chemotherapeutic and pharmacological preparations]. Antibiotiki (1976) 0.75
[Effect of antibiotics on microbial adhesion]. Antibiot Khimioter (1990) 0.75
[Pharmacokinetics of ampicillin in patients with gastric and duodenal ulcers and patients having undergone Billroth II gastric resection]. Antibiot Med Biotekhnol (1985) 0.75
[Ampicillin pharmacokinetics in prostatic adenoma patients]. Antibiot Med Biotekhnol (1987) 0.75
[Experience in using an antibiotic from the aminoglycoside group, gentamicin (garamycin), in the surgical clinic]. Klin Med (Mosk) (1972) 0.75
[Pharmacokinetics of dihaloid substituted isoxazolyl penicillins]. Antibiotiki (1973) 0.75
[Cefpirome-- a new 4th generation cephalosporin antibiotic]. Antibiot Khimioter (1996) 0.75
[Cephalosporin pharmacokinetics in rabbits]. Antibiotiki (1981) 0.75
[Symposium "Ciflozin (ciprofloxacin)--a broad-spectrum antibacterial drug"]. Antibiot Khimioter (1992) 0.75
[Ofloxacin in the comprehensive therapy of complicated forms of wound infection]. Antibiot Khimioter (1994) 0.75
[Comparative study of the circulation of semisynthetic cephalosporins in the blood of rabbits]. Antibiotiki (1975) 0.75
[Experimental therapy of burn infection caused by pyocyanic bacilli]. Farmakol Toksikol (1976) 0.75
[Macrolide antibiotics for oral intake in the treatment and prevention of suppurative surgical infection]. Antibiotiki (1976) 0.75
[Interactions of sulfanilamides, penicillins and acetylsalicylic acid in serum protein binding]. Antibiot Khimioter (1988) 0.75
[Effect of acetylsalicylic acid on sulfalene and sulfadimethoxine binding by serum proteins and on their kinetics in rabbits]. Antibiotiki (1984) 0.75
[Sulperazone--a combined form of cefoperazone with sulbactam]. Antibiot Khimioter (1995) 0.75
[Effect of kanamycin and florimycin on intracellular located Mycobacterium tuberuclosis and some regularities of interaction of these antibiotics with body cells]. Antibiotiki (1969) 0.75
[Pharmacokinetics of cefamandole in rabbits]. Antibiotiki (1982) 0.75
[Comparative study of interaction of streptomycin and dihydrostreptomycin with macrophages cultivated in vitro]. Antibiotiki (1970) 0.75
[Pharmacokinetics of semisynthetic cephalosporins for parenteral use on surgical patients]. Antibiotiki (1978) 0.75
[Netilmicin]. Antibiot Khimioter (1994) 0.75
[Symposium "Abactal (pefloxacin)--new possibilities in antibacterial therapy"]. Antibiot Khimioter (1991) 0.75
[Use of penicillinase resistant penicillins for the treatment of surgical suppurative infection]. Klin Med (Mosk) (1973) 0.75
[Sulfalene circulation in kidney disease patients]. Antibiotiki (1981) 0.75
[Results of clinical and laboratory studies of anaerobic non-clostridial infection in a surgical clinic]. Vestn Ross Akad Med Nauk (1996) 0.75
[Circulation of polysynthetic broad spectrum penicillins in patients with urolithiasis]. Antibiotiki (1970) 0.75
[Comparative study of circulation of oxacillin and cloxacillin in the organism of rabbits]. Antibiotiki (1969) 0.75
[Circulation of ampicillin and sulfalene in liver disease patients]. Antibiotiki (1982) 0.75
[Pharmacokinetic interference between furosemide and cephalosporins]. Antibiotiki (1981) 0.75
[Study of ampicillin distribution in cases with purulent and tumor diseases of the lungs]. Antibiotiki (1972) 0.75
[Empirical antibiotic therapy of wounds complicated by anaerobic non-clostridial infection]. Antibiot Khimioter (1989) 0.75
[Pharmacokinetics of penicillins following combined administration with sulfanilamides]. Antibiotiki (1983) 0.75
[Absorption of streptomycin by macrophages cultivated in vitro and possible role of cell components in that process]. Antibiotiki (1969) 0.75
[Comparative study of the interaction of cephalosporins with blood serum proteins and organ homogenates]. Antibiotiki (1979) 0.75
[Antibiotic pharmacokinetics in rats with an infected inflammation]. Antibiot Med Biotekhnol (1987) 0.75
[Clearance indices of penicillins in rabbits]. Antibiotiki (1972) 0.75
[Pharmacokinetics of rifamycin]. Antibiotiki (1978) 0.75
[Comparative study of the distribution of semisynthetic cephalosporins in the body of rats]. Antibiotiki (1979) 0.75
[Circulation of some phenoxyalkylpenicillins in the body of rabbits]. Antibiotiki (1970) 0.75
[The dynamics of doxycycline circulation in patients with traumatic lesions of the spinal cord]. Antibiotiki (1972) 0.75
[Sulfadimethoxine pharmacokinetics in chronic nephritis with nephrotic syndrome]. Antibiotiki (1981) 0.75
[Use of a new drug, lomefloxacin (maxaquin), from the fluoroquinolone group in the treatment of patients with wound infection]. Antibiot Khimioter (1994) 0.75
[Effect of sulfalene and furosemide on benzylpenicillin kinetics in rats with aseptic inflammation]. Antibiot Khimioter (1988) 0.75
[Cefpiramide (Tamicin) in the treatment of purulent complications of abdominal surgery]. Antibiot Khimioter (1995) 0.75
[Aztreonam]. Antibiot Khimioter (1992) 0.75
[A trial of using Cefobid (cefoperazone) in treating infections of the skin and soft tissues]. Antibiot Khimioter (1994) 0.75
[Cefpiramide--a new cephalosporin antibiotic]. Antibiot Khimioter (1994) 0.75
[Pharmacokinetics of ampicillin in patients with chronic renal insufficiency during hemodialysis and hemosorption]. Antibiot Med Biotekhnol (1985) 0.75
[Ciprofloxacin in the prevention and treatment of surgical infections]. Antibiot Khimioter (1991) 0.75
[Pharmacokinetics of fluoroquinolones in patients with renal insufficiency]. Antibiot Khimioter (1995) 0.75
[Pharmacokinetics of carbenicillin in patients with traumatic lesions of the spinal cord]. Antibiotiki (1971) 0.75
[Pharmacokinetics of benzylpenicillin and ampicillin in patients after combined administration with sulfalen and sulfadimethoxine]. Antibiot Med Biotekhnol (1987) 0.75
[Absorption of tetracycline by macrophages cultivated outside the host organism]. Antibiotiki (1967) 0.75
[Distribution of antibiotics of the tetracycline group in rats during experimental infection]. Antibiotiki (1968) 0.75
[A comparative study of the circulation of oxytetracycline and its derivatives--methacycline and doxycycline--in the bodies of animals]. Antibiotiki (1973) 0.75
[Experience in the clinical use of rifamycin SV]. Antibiotiki (1972) 0.75